World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN33488737
Date of registration: 23/01/2004
Prospective Registration: No
Primary sponsor: NHS R&D Regional Programme Register - Department of Health (UK)
Public title: Effectiveness of Patient Controlled Epidural Analgesia (PCEA) compared with Continuous Epidural Infusion Analgesia (CEIA) in patients undergoing elective Large Bowel Resection
Scientific title:
Date of first enrolment: 01/10/2000
Target sample size: 0
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN33488737
Study type:  Interventional
Study design:  Randomised controlled trial (Not Specified)  
Phase: 
Countries of recruitment
United Kingdom
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Jeremy    Nightingale
Address:  Anaesthetic Department Portsmouth Hospitals NHS Trust Queen Alaxandra Hospital Southwick Hill Road Cosham PO6 3LY Portsmouth United Kingdom
Telephone: +44 (0)1705 286279
Email: captainsensible@soberton.swinternet.co.uk
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Adult patients admitted to the Queen Alexandra Hospital for elective large bowel resection will be approached.
Exclusion criteria: Patients with contra-indication to epidural analgesia, poor co-ordination and hand arthritis.

Age minimum:
Age maximum:
Gender: Not Specified
Health Condition(s) or Problem(s) studied
Symptoms and general pathology: Pain
Signs and Symptoms
Pain
Intervention(s)
i. PCEA or ii. CEIA using Bupivacaine 0.125% with Fentanyl 4 µg/ml via a Graseby 9500 pump. Patients in both groups will receive a loading dose of bupivacaine 0.25% via the epidural catheter, which is then attached to the pump. For patients in the CEIA group (controls) the pump will be programmed to deliver a continuous infusion of 10 ml/hour but the patient demand button will be disabled although it will still make a 'click noise' when pressed. For those in the PCEA arm, the pump will be programmed to deliver a continual dose of 8 ml/hour and a bolus dose of 3 ml on activation of the patient demand button, with a lockout interval of 20 min.
Primary Outcome(s)
a. Pain scores: This will be recorded using the hospital standard system which has been adopted by Wessex Acute Pain Forum as part of the minimum data set. It is a simple numerical scale of 0-3. In addition a standard 10 cm Vas marked at either extreme is used. Data will be collected hourly for the first 4 hours and 4 hourly thereafter. Patient will be scored at rest and on movement.
b. Patient's perception on control: In order to incorporate the notion of control we will utilise a standardised questionnaire to measure 'beliefs about controlling pain'
c. Patient's overall satisfaction of their pain control: at 72 hours and on discharge (between days 7-10), patients will be asked to record their overall impression of their pain control
d. Side effects: All patients will be assessed for incidence of sedation, nausea and vomiting, and respiratory depression. Pruritus and urinary retention will be noted and treated accordingly.
e. Analgesia usage: Consumption of epidural drugs and requirement for rescue analgesia will be recorded for all patients
Secondary Outcome(s)
Not provided at time of registration
Secondary ID(s)
SEO130
Source(s) of Monetary Support
NHS Executive South East (UK)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history